Development and safety of PI3K inhibitors in cancer

M Yu, J Chen, Z Xu, B Yang, Q He, P Luo, H Yan… - Archives of …, 2023 - Springer
Abstract The phosphatidylinositol 3-kinase (PI3K) signalling pathway regulates cell survival,
proliferation, migration, metabolism and other vital cellular life processes. In addition …

Prognosis and dissection of immunosuppressive microenvironment in breast cancer based on fatty acid metabolism-related signature

Y Tang, W Tian, J Xie, Y Zou, Z Wang, N Li… - Frontiers in …, 2022 - frontiersin.org
Fatty acid metabolism has been deciphered to augment tumorigenesis and disease
progression in addition to therapy resistance via strengthened lipid synthesis, storage, and …

The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts

M McKenna, S McGarrigle, GP Pidgeon - Biochimica et Biophysica Acta …, 2018 - Elsevier
Abstract The PI3K/Akt/mTOR pathway plays a role in various oncogenic processes in breast
cancer and key pathway aberrations have been identified which drive the different molecular …

PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity

LS Carnevalli, C Sinclair, MA Taylor… - … for immunotherapy of …, 2018 - Springer
PI3K inhibitors with differential selectivity to distinct PI3K isoforms have been tested
extensively in clinical trials, largely to target tumor epithelial cells. PI3K signaling also …

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma

W Xu, P Berning, T Erdmann, M Grau, N Bettazová… - Leukemia, 2023 - nature.com
Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease that exhibits constitutive
activation of phosphoinositide 3-kinase (PI3K) driven by chronic B-cell receptor signaling or …

Statin use is associated with lower risk of PTEN-null and lethal prostate cancer

EH Allott, EM Ebot, KH Stopsack… - Clinical Cancer …, 2020 - AACR
Purpose: Statins are associated with lower risk of aggressive prostate cancer, but lethal
prostate cancer is understudied and contributing mechanisms are unclear. We prospectively …

Targeting class I-II-III PI3Ks in cancer therapy: recent advances in tumor biology and preclinical research

B Thibault, F Ramos-Delgado, J Guillermet-Guibert - Cancers, 2023 - mdpi.com
Simple Summary The PI3K/AKT pathway is one of the most important signaling nodes in
cancer. While class I PI3K roles in cancer are well known, class II and III functions in …

Development of PI3Kγ selective inhibitors: the strategies and application

D Gu, M Zhang, J Li, Y Zhou, R Sheng - Acta Pharmacologica Sinica, 2024 - nature.com
The γ isoform of Class I PI3Ks (PI3Kγ) is primarily found in leukocytes and is essential for the
function of myeloid cells, as it regulates the migration, differentiation, and activation of …

[HTML][HTML] Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase

Y Okawa, N Ebata, NKD Kim, M Fujita, K Maejima… - Oncotarget, 2021 - ncbi.nlm.nih.gov
Introduction: Treatment options for biliary tract cancer (BTC) are very limited. It is necessary
to investigate actionable genes and candidate drugs using a sophisticated knowledgebase …

IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy

Q Luo, J Zhuang, D Zheng, C Miao, H Luo… - Frontiers in …, 2023 - frontiersin.org
Introduction Copper metabolism encompasses all cellular metabolic processes involving
copper ions and plays a significant role in the pathogenesis of diseases, including cancer …